Eli Lilly drug shows significant results in slowing symptoms of Alzheimer's disease
Eli Lilly drug shows significant results in slowing Alzheimerâs The experimental drug, donanemab, was studied at two R.I. hospitals By Alexa Gagosz Globe Staff,Updated March 15, 2021, 2:32 p.m. Email to a Friend Dr. Stephen Salloway is the director of the Memory and Aging Program at Butler Hospital, where he led the TRAILBLAZER study. He is also a professor of psychiatry and human behavior and of neurology at Brown Universityâs Warren Alpert Medical School.Nick Dentamaro/Brown University PROVIDENCE â Rhode Island is once again playing a critical role in the development of prom...
Source: bostonglobe.com